Holen Sie sich die Stockscreener-App
10.06
5.18%
-0.55
Handel nachbörslich:
10.26
0.20
+1.99%
Schlusskurs vom Vortag:
$10.61
Offen:
$10.6
24-Stunden-Volumen:
16,854
Relative Volume:
1.10
Marktkapitalisierung:
$86.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.45M
KGV:
-0.4634
EPS:
-21.71
Netto-Cashflow:
$-31.81M
1W Leistung:
-2.89%
1M Leistung:
+15.50%
6M Leistung:
-5.98%
1J Leistung:
+53.36%
1-Tages-Spanne:
$10.06
$11.73
1-Wochen-Bereich:
$9.03
$11.73
52-Wochen-Spanne:
$5.90
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Vergleichen Sie SRZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
10.06 | 90.85M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
Using R and stats models for Surrozen Inc. Equity Warrant forecastingPortfolio Risk Report & Reliable Entry Point Alerts - Newser
Analyzing drawdowns of Surrozen Inc. Equity Warrant with statistical toolsTrade Performance Summary & Growth Focused Entry Point Reports - Newser
Developing predictive dashboards with Surrozen Inc. dataJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
Historical volatility pattern of Surrozen Inc. Equity Warrant visualizedTreasury Yields & Proven Capital Preservation Tips - Newser
Surrozen Inc. stock prediction for this weekTrade Performance Summary & Smart Swing Trading Techniques - Newser
Can trapped investors hope for a rebound in Surrozen Inc. Equity WarrantStock Surge & Weekly High Return Stock Opportunities - Newser
What indicators show strength in Surrozen Inc. Equity WarrantWeekly Earnings Recap & AI Enhanced Trading Signals - Newser
How to escape a deep drawdown in Surrozen Inc. Equity Warrant2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Surrozen Inc. Equity Warrant stock volume spike explained2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Real time breakdown of Surrozen Inc. stock performance2025 Technical Overview & Community Consensus Picks - Newser
Does Surrozen Inc. have a competitive edgeJuly 2025 Reactions & Long-Term Safe Investment Ideas - newsyoung.net
How to build a custom watchlist for Surrozen Inc. [Trade Entry Report]Capital Efficiency Focused Ideas - Newser
What institutional flow reveals about Surrozen Inc. Equity WarrantConservative Investment Setup and Risk Analysis - Newser
Surrozen Inc. stock chart pattern explainedBuy and Exit Strategy Based on Momentum - Newser
Surrozen Inc.’s volatility index tracking explainedWeekly Stock Picks with Trend Confidence - Newser
Key metrics from Surrozen Inc.’s quarterly dataSmart Stock Forecast Using AI Algorithms - Newser
Why Surrozen Inc. stock attracts strong analyst attentionInvestment Life Cycle Planning Summary - Newser
What technical models suggest about Surrozen Inc. Equity Warrant’s comeback - Newser
Will earnings trigger a reversal in Surrozen Inc.Free Swing Trade Entry With Volume Triggers - Newser
Can Surrozen Inc. Equity Warrant hit a new high this monthFree Weekly Growth Stock Entry Point Alerts - Newser
Detecting price anomalies in Surrozen Inc. with AIOversold Reversal Picks with Buy Zone - Newser
What makes Surrozen Inc. Equity Warrant stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
What MACD and RSI say about Surrozen Inc. Equity WarrantFree Proven Entry Plan With Low Risk Trade - Newser
Surrozen’s Q2 2025: Progress in Eye Disease Therapies - TipRanks
Why Surrozen Inc. Equity Warrant stock attracts strong analyst attentionFree Trade Timing Strategy With Technical Data - Newser
Has Surrozen Inc. formed a bullish divergenceAI Trend Detection for Entry Timing - Newser
What makes Surrozen Inc. stock price move sharplyDay Trading Setup and Momentum Analysis - Newser
Analyzing net buyer seller activity in Surrozen Inc. Equity WarrantFree Smart Trade Plans With Risk Protection - Newser
How to forecast Surrozen Inc. trends using time seriesLow Drawdown Stock Screener with Analysis - Newser
How to build a custom watchlist for Surrozen Inc.3-Day Market Movement Forecast Analysis - Newser
What MACD and RSI say about Surrozen Inc. Equity Warrant [Earnings Miss]Safe Swing Trade Setups - Newser
Does Surrozen Inc. show high probability of reboundRisk Aware Trading Ideas with Alert Levels - Newser
Surrozen Inc. Equity Warrant stock trend forecastValue Holding Return Summary With Outlook - Newser
Is Surrozen Inc. building a consolidation basePredicted Market Direction Based on Momentum - Newser
How to manage a losing position in Surrozen Inc. Equity WarrantDaily Investment Ideas with Market Insight - Newser
Surrozen Inc. Equity Warrant stock chart pattern explained7-Day Equity Return Range Forecast Model - Newser
Surrozen's Q2 2025 Earnings: A Biotech Turnaround Driven by Strategic Gains and Ophthalmology Pipeline Progress - AInvest
Technical analysis overview for Surrozen Inc. stockFree Real Time Alerts Based on AI Prediction - Newser
Published on: 2025-08-09 11:37:11 - beatles.ru
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):